AI assistant
TherapeuticsMD, Inc. — Director's Dealing 2012
Mar 16, 2012
35134_dirs_2012-03-16_fbff13af-ad97-4c11-8ce2-82de5e037c90.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3/A — Form 3/A
Issuer: TherapeuticsMD, Inc. (TXMD)
CIK: 0000025743
Period of Report: 2011-10-04
Reporting Person: Milligan John C.K. IV (Director, President, Secretary, 10% Owner)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 6368018 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Non-qualified Stock Option | $0.1018 | 2019-01-01 | Common Stock (2052255) | Direct | |
| Common Stock Purchase Warrant | $0.4074 | 2021-06-06 | Common Stock (61372) | Direct | |
| Common Stock Purchase Warrant | $0.2444 | 2011-03-09 | Common Stock (204571) | Direct |
Footnotes
F1: Option vests at the rate of 6,137 shares per month over the first year from the date of issuance. Shares vested to date are 73,646. This option was assumed and re-issued pursuant to the Merger Agreement between the Company and VitaMedMD, LLC which closed on October 4, 2011.
F2: Warrant vested on issuance. This warrant was assumed and re-issued pursuant to the Merger Agreement between the Company and VitaMedMD, LLC which closed on October 4, 2011.
F3: Warrants rest at the rate of 25,571 shares per calender quarter.